questionsmedicales.fr
Régions géographiques
Océanie
Australasie
Australasie : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Maladies tropicales
Diagnostic médical
Paludisme
Tests de diagnostic
Virus Zika
Infections virales
Maladie de Lyme
Diagnostic médical
Symptômes
5
Virus de l'herpès
Infections virales
Intoxication alimentaire
Symptômes
Infections respiratoires
Symptômes
Prévention
5
Infections respiratoires
Prévention
Traitements
5
Maladie de Lyme
Traitements
Complications
5
Chikungunya
Complications
Leptospirose
Complications
Maladie de Lyme
Complications
Facteurs de risque
5
Dengue
Facteurs de risque
Chikungunya
Facteurs de risque
Virus Zika
Facteurs de risque
Leptospirose
Facteurs de risque
Maladie de Lyme
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Australasie : Questions médicales les plus fréquentes",
"headline": "Australasie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Australasie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-22",
"dateModified": "2025-04-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Australasie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Océanie",
"url": "https://questionsmedicales.fr/mesh/D044349",
"about": {
"@type": "MedicalCondition",
"name": "Océanie",
"code": {
"@type": "MedicalCode",
"code": "D044349",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Australie",
"alternateName": "Australia",
"url": "https://questionsmedicales.fr/mesh/D001315",
"about": {
"@type": "MedicalCondition",
"name": "Australie",
"code": {
"@type": "MedicalCode",
"code": "D001315",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Territoire de la capitale australienne",
"alternateName": "Australian Capital Territory",
"url": "https://questionsmedicales.fr/mesh/D020958",
"about": {
"@type": "MedicalCondition",
"name": "Territoire de la capitale australienne",
"code": {
"@type": "MedicalCode",
"code": "D020958",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nouvelle-Galles du Sud",
"alternateName": "New South Wales",
"url": "https://questionsmedicales.fr/mesh/D009517",
"about": {
"@type": "MedicalCondition",
"name": "Nouvelle-Galles du Sud",
"code": {
"@type": "MedicalCode",
"code": "D009517",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Territoire du Nord",
"alternateName": "Northern Territory",
"url": "https://questionsmedicales.fr/mesh/D015876",
"about": {
"@type": "MedicalCondition",
"name": "Territoire du Nord",
"code": {
"@type": "MedicalCode",
"code": "D015876",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.875"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Queensland",
"alternateName": "Queensland",
"url": "https://questionsmedicales.fr/mesh/D011793",
"about": {
"@type": "MedicalCondition",
"name": "Queensland",
"code": {
"@type": "MedicalCode",
"code": "D011793",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.937"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Australie-Méridionale",
"alternateName": "South Australia",
"url": "https://questionsmedicales.fr/mesh/D013021",
"about": {
"@type": "MedicalCondition",
"name": "Australie-Méridionale",
"code": {
"@type": "MedicalCode",
"code": "D013021",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.968"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tasmanie",
"alternateName": "Tasmania",
"url": "https://questionsmedicales.fr/mesh/D013648",
"about": {
"@type": "MedicalCondition",
"name": "Tasmanie",
"code": {
"@type": "MedicalCode",
"code": "D013648",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.984"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Victoria",
"alternateName": "Victoria",
"url": "https://questionsmedicales.fr/mesh/D014739",
"about": {
"@type": "MedicalCondition",
"name": "Victoria",
"code": {
"@type": "MedicalCode",
"code": "D014739",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.992"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Australie occidentale",
"alternateName": "Western Australia",
"url": "https://questionsmedicales.fr/mesh/D014904",
"about": {
"@type": "MedicalCondition",
"name": "Australie occidentale",
"code": {
"@type": "MedicalCode",
"code": "D014904",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.996"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Nouvelle-Zélande",
"alternateName": "New Zealand",
"url": "https://questionsmedicales.fr/mesh/D009520",
"about": {
"@type": "MedicalCondition",
"name": "Nouvelle-Zélande",
"code": {
"@type": "MedicalCode",
"code": "D009520",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.747"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Iles du Pacifique",
"alternateName": "Pacific Islands",
"url": "https://questionsmedicales.fr/mesh/D010139",
"about": {
"@type": "MedicalCondition",
"name": "Iles du Pacifique",
"code": {
"@type": "MedicalCode",
"code": "D010139",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.873"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Australasie",
"alternateName": "Australasia",
"code": {
"@type": "MedicalCode",
"code": "D044362",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Ainsley J Newson",
"url": "https://questionsmedicales.fr/author/Ainsley%20J%20Newson",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Medicine and Health, Sydney School of Public Health, Sydney Health Ethics, The University of Sydney, Sydney, NSW, Australia."
}
},
{
"@type": "Person",
"name": "Thomas Beaney",
"url": "https://questionsmedicales.fr/author/Thomas%20Beaney",
"affiliation": {
"@type": "Organization",
"name": "Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, UK."
}
},
{
"@type": "Person",
"name": "Xin Xia",
"url": "https://questionsmedicales.fr/author/Xin%20Xia",
"affiliation": {
"@type": "Organization",
"name": "Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, UK."
}
},
{
"@type": "Person",
"name": "Neil R Poulter",
"url": "https://questionsmedicales.fr/author/Neil%20R%20Poulter",
"affiliation": {
"@type": "Organization",
"name": "Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, UK."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Completeness of variables in Hospital-Based Cancer Registries for prostatic malignant neoplasm.",
"datePublished": "2024-07-29",
"url": "https://questionsmedicales.fr/article/39082550",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/0034-7167-2023-0467"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hepatic Small Vessel Neoplasm Mimics Prostate Cancer on 18 F-DCFPyl PET/CT.",
"datePublished": "2023-01-14",
"url": "https://questionsmedicales.fr/article/36728165",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/RLU.0000000000004554"
}
},
{
"@type": "ScholarlyArticle",
"name": "Granulomatous prostatitis: mimicking locally advanced prostate adenocarcinoma.",
"datePublished": "2023-10-17",
"url": "https://questionsmedicales.fr/article/37850783",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.23750/abm.v94i5.13751"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinicopathological and immunological profiles of prostate adenocarcinoma and neuroendocrine prostate cancer.",
"datePublished": "2022-12-27",
"url": "https://questionsmedicales.fr/article/36572885",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12957-022-02841-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "The influence of prostate volume on clinical parameters in prostate cancer screening.",
"datePublished": "2022-09-13",
"url": "https://questionsmedicales.fr/article/36098911",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jcla.24700"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Régions géographiques",
"item": "https://questionsmedicales.fr/mesh/D005842"
},
{
"@type": "ListItem",
"position": 3,
"name": "Océanie",
"item": "https://questionsmedicales.fr/mesh/D044349"
},
{
"@type": "ListItem",
"position": 4,
"name": "Australasie",
"item": "https://questionsmedicales.fr/mesh/D044362"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Australasie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Australasie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Australasie",
"description": "Comment diagnostiquer une maladie tropicale en Australasie ?\nQuels tests sont utilisés pour le paludisme en Australasie ?\nComment identifier une infection par le virus Zika ?\nQuels sont les signes d'une infection à leptospirose ?\nComment diagnostiquer une maladie de Lyme en Australasie ?",
"url": "https://questionsmedicales.fr/mesh/D044362?mesh_terms=Prostatic+Neoplasms#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Australasie",
"description": "Quels sont les symptômes du chikungunya ?\nComment se manifeste la dengue ?\nQuels signes indiquent une infection par le virus de l'herpès ?\nQuels symptômes d'une intoxication alimentaire ?\nComment reconnaître une infection respiratoire ?",
"url": "https://questionsmedicales.fr/mesh/D044362?mesh_terms=Prostatic+Neoplasms#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Australasie",
"description": "Comment prévenir la dengue en Australasie ?\nQuelles mesures pour éviter le chikungunya ?\nComment se protéger contre le virus Zika ?\nQuelles sont les recommandations pour la leptospirose ?\nComment prévenir les infections respiratoires ?",
"url": "https://questionsmedicales.fr/mesh/D044362?mesh_terms=Prostatic+Neoplasms#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Australasie",
"description": "Quels traitements pour la dengue ?\nComment traiter une infection par le virus Zika ?\nQuels médicaments pour le chikungunya ?\nComment traiter une infection à leptospirose ?\nQuels sont les traitements pour la maladie de Lyme ?",
"url": "https://questionsmedicales.fr/mesh/D044362?mesh_terms=Prostatic+Neoplasms#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Australasie",
"description": "Quelles complications peuvent survenir avec la dengue ?\nQuels risques associés au chikungunya ?\nQuelles complications de l'infection par le virus Zika ?\nQuelles complications de la leptospirose ?\nQuels risques de la maladie de Lyme non traitée ?",
"url": "https://questionsmedicales.fr/mesh/D044362?mesh_terms=Prostatic+Neoplasms#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Australasie",
"description": "Quels sont les facteurs de risque pour la dengue ?\nQui est à risque pour le chikungunya ?\nQuels facteurs augmentent le risque de virus Zika ?\nQuels sont les risques associés à la leptospirose ?\nQui est à risque pour la maladie de Lyme ?",
"url": "https://questionsmedicales.fr/mesh/D044362?mesh_terms=Prostatic+Neoplasms#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une maladie tropicale en Australasie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic repose sur l'historique médical, les symptômes et des tests de laboratoire."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le paludisme en Australasie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de diagnostic incluent les frottis sanguins et les tests de dépistage rapide."
}
},
{
"@type": "Question",
"name": "Comment identifier une infection par le virus Zika ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'infection est confirmée par des tests sanguins spécifiques et l'historique de voyage."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une infection à leptospirose ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, douleurs musculaires et éruption cutanée, nécessitant des tests."
}
},
{
"@type": "Question",
"name": "Comment diagnostiquer une maladie de Lyme en Australasie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'exposition aux tiques et des tests sérologiques spécifiques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes du chikungunya ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, douleurs articulaires et éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Comment se manifeste la dengue ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "La dengue se manifeste par une forte fièvre, des douleurs corporelles et des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une infection par le virus de l'herpès ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des lésions cutanées, des démangeaisons et des douleurs localisées."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une intoxication alimentaire ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent nausées, vomissements, diarrhée et douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une infection respiratoire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux, fièvre, essoufflement et douleurs thoraciques."
}
},
{
"@type": "Question",
"name": "Comment prévenir la dengue en Australasie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éliminer les eaux stagnantes et utiliser des répulsifs contre les moustiques."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour éviter le chikungunya ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des moustiquaires et des répulsifs, et éviter les zones infestées."
}
},
{
"@type": "Question",
"name": "Comment se protéger contre le virus Zika ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les piqûres de moustiques et utiliser des préservatifs lors de rapports sexuels."
}
},
{
"@type": "Question",
"name": "Quelles sont les recommandations pour la leptospirose ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le contact avec des eaux potentiellement contaminées et porter des vêtements de protection."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections respiratoires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains régulièrement et éviter les contacts avec des personnes malades."
}
},
{
"@type": "Question",
"name": "Quels traitements pour la dengue ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement est symptomatique, avec des analgésiques et une hydratation adéquate."
}
},
{
"@type": "Question",
"name": "Comment traiter une infection par le virus Zika ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement spécifique ; le repos et l'hydratation sont recommandés."
}
},
{
"@type": "Question",
"name": "Quels médicaments pour le chikungunya ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anti-inflammatoires et les analgésiques sont utilisés pour soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Comment traiter une infection à leptospirose ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement comprend des antibiotiques et un suivi médical pour éviter les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements pour la maladie de Lyme ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques sont le traitement principal, surtout s'ils sont administrés tôt."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la dengue ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la dengue sévère, pouvant entraîner des hémorragies et un choc."
}
},
{
"@type": "Question",
"name": "Quels risques associés au chikungunya ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs articulaires chroniques peuvent persister longtemps après l'infection."
}
},
{
"@type": "Question",
"name": "Quelles complications de l'infection par le virus Zika ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le virus peut causer des malformations congénitales si contracté pendant la grossesse."
}
},
{
"@type": "Question",
"name": "Quelles complications de la leptospirose ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des lésions rénales, hépatiques et des hémorragies pulmonaires."
}
},
{
"@type": "Question",
"name": "Quels risques de la maladie de Lyme non traitée ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des problèmes neurologiques et des douleurs articulaires chroniques."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour la dengue ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent vivre dans des zones tropicales et avoir des antécédents d'infection."
}
},
{
"@type": "Question",
"name": "Qui est à risque pour le chikungunya ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées et celles avec des maladies chroniques sont plus vulnérables."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de virus Zika ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Voyager dans des zones endommagées par le virus et être enceinte augmentent le risque."
}
},
{
"@type": "Question",
"name": "Quels sont les risques associés à la leptospirose ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes travaillant en milieu rural ou en contact avec des eaux contaminées sont à risque."
}
},
{
"@type": "Question",
"name": "Qui est à risque pour la maladie de Lyme ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes vivant dans des zones boisées ou ayant des activités de plein air sont à risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 17/04/2025
Contenu vérifié selon les dernières recommandations médicales
12 publications dans cette catégorie
5 publications dans cette catégorie
Affiliations :
Faculty of Medicine and Health, Sydney School of Public Health, Sydney Health Ethics, The University of Sydney, Sydney, NSW, Australia.
Publications dans "Australasie" :
5 publications dans cette catégorie
Affiliations :
Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, UK.
Publications dans "Australasie" :
5 publications dans cette catégorie
Affiliations :
Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, UK.
Publications dans "Australasie" :
5 publications dans cette catégorie
Affiliations :
Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, UK.
Publications dans "Australasie" :
4 publications dans cette catégorie
Affiliations :
Hunter Genetics, Waratah, NSW, Australia.
Publications dans "Australasie" :
4 publications dans cette catégorie
Affiliations :
International Union of Phlebology (UIP), Chatswood, NSW, Australia.
Australasian College of Phlebology (ACP), Chatswood, NSW, Australia.
Publications dans "Australasie" :
4 publications dans cette catégorie
Affiliations :
International Union of Phlebology (UIP), Chatswood, NSW, Australia.
European College of Phlebology (ECoP), Rotterdam, The Netherlands.
Publications dans "Australasie" :
4 publications dans cette catégorie
Affiliations :
550809American Venous Forum (AVF), East Dundee, IL, USA.
Publications dans "Australasie" :
4 publications dans cette catégorie
Affiliations :
550809American Venous Forum (AVF), East Dundee, IL, USA.
Publications dans "Australasie" :
4 publications dans cette catégorie
Affiliations :
Australasian College of Phlebology (ACP), Chatswood, NSW, Australia.
Interventional Radiology Society of Australasia (IRSA), Ultimo, NSW, Australia.
Publications dans "Australasie" :
3 publications dans cette catégorie
Affiliations :
Genetic Counseling, Graduate School of Health, University of Technology Sydney, Sydney, New South Wales, Australia.
Publications dans "Australasie" :
3 publications dans cette catégorie
Affiliations :
Melbourne Law School, University of Melbourne, Melbourne, VIC, Australia.
Biomedical Ethics Research Group, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Publications dans "Australasie" :
3 publications dans cette catégorie
Affiliations :
Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Melbourne Genomics Health Alliance, Melbourne, VIC, Australia.
Australian Genomics Health Alliance, Melbourne, VIC, Australia.
Publications dans "Australasie" :
3 publications dans cette catégorie
Affiliations :
Department of Clinical Research, Dobney Hypertension Centre, School of Medicine, Royal Perth Hospital Unit, University of Western Australia, Level 3, MRF Building, Rear 50 Murray St, Perth, WA MDBP M570, Australia.
Publications dans "Australasie" :
2 publications dans cette catégorie
Affiliations :
Australasian Institute of Digital Health, Australia.
Publications dans "Australasie" :
2 publications dans cette catégorie
Affiliations :
Australasian Institute of Digital Health, Australia.
University of Technology Sydney, Australia.
Publications dans "Australasie" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
Publications dans "Australasie" :
2 publications dans cette catégorie
Affiliations :
Department of Biomedical and Clinical Sciences L. Sacco, Università degli Studi di Milano, Milan, Italy.
Publications dans "Australasie" :
2 publications dans cette catégorie
Affiliations :
School of Medicine, Deakin University, Geelong, Australia.
Publications dans "Australasie" :
to analyze the completeness of variables from Hospital-Based Cancer Registries of cases of prostate neoplasm in the Oncology Care Network of a Brazilian state between 2000 and 2020....
an ecological time series study, based on secondary data on prostate cancer Hospital-Based Cancer Registries prostate. Data incompleteness was classified as excellent (<5%), good (between 5%-10%), fai...
there were 13,519 cases of prostate cancer in the Hospital-Based Cancer Registries analyzed. The variables "family history of cancer" (p<0.001), "alcoholism" (p<0.001), "smoking" (p<0.001), "TNM stagi...
most Hospital-Based Cancer Registries variables showed excellent completeness, but important variables had high percentages of incompleteness, such as TNM and clinical staging, in addition to alcoholi...
18 F-DCFPyl is a Food and Drug Administration-approved radiotracer that targets prostate-specific membrane antigen and is used in the detection of recurrent or metastatic prostate cancer. As its use h...
We report the case of a 63-year-old male who came to the urology clinic with an increasing value of the prostate specific antigen and an asymmetrical enlargement at the digital rectal examination. The...
Biomarkers of DNA damage repair deficiency provide opportunities for personalized treatment with immunotherapy. However, there is limited research on the immune microenvironment of adeno-neuroendocrin...
A retrospective medical record review of 66 patients with prostate cancer (PCa) was performed. PCa samples from the 66 patients were analyzed using immunohistochemical staining for the detection of ch...
Twenty patients presented with adeno-NEPC, whereas 46 presented with adeno-PCa. The median age of patients at PCa diagnosis was 67.86 ± 7.05 years (68.65 ± 7.23 years, adeno-NEPC; 67.52 ± 7.02 years, ...
Our study revealed clinicopathological manifestations of adeno-NEPC and some possible predictive factors significantly associated with better outcomes in patients with adeno-NEPC. These findings might...
The purpose of the study was to evaluate the diagnostic significance of two new and a few clinical markers for prostate cancer (PCa) at various prostate volumes (PV)....
The study subjects were divided into two groups. Among them, there were 70 cases in the PV ≤30 ml group (benign prostatic hyperplasia [BPH]: 32 cases, PCa: 38 cases) and 372 cases in the PV > 30 ml gr...
In the PV ≤30 ml group, the diagnostic parameters based on prostate-specific antigen (PSA) had a decreased diagnostic significance for PCa. In the PV > 30 ml group, PSAD (AUC = 0.709), AVR (AVR = Age/...
Choosing appropriate indicators for different PVs could contribute to the early screening and diagnosis of PCa. The difference in the diagnostic value of two new indicators (A-PSAD and AVR), and PSAD ...
The optimal treatment of metastatic castration-resistant prostate cancer (mCRPC) continues to be challenging, given the multitude of life prolonging treatment options. Radionuclide therapy delivers co...
This study aims to compare the ability of the PHI versus tPSA test to predict the presence of PCa in our population....
A prospective observational study was performed. We included patients with tPSA ≥ 2.5 ng/ml, biopsy naïve or previous negative biopsy, undergoing a blood test, which includes tPSA, fPSA, and p2PSA, an...
140 men were included. Fifty-seven (40.7%) had a positive prostate biopsy result (Group A), and 83 (59.3%) had a negative biopsy result (Group B). The mean age was similar in both groups (mean ± stand...
The PHI test improves PCa detection compared to tPSA in our population....
Holmium laser enucleation of the prostate (HoLEP) is a size-independent surgical option for treating benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) with excellent, durable ...
Noninvasive methods for the early identify diagnosis of prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer (PCa) are current clinical challenges....
The serum metabolites of 20 healthy individuals and patients with prostatitis, BPH, or PCa were identified using untargeted liquid chromatography-mass spectrometry (LC-MS). In addition, targeted LC-MS...
Organic acid metabolites had good sensitivity and specificity in differentiating prostatitis, BPH, and PCa. Three diagnostic models identified patients with PROSTATITIS: phenyllactic acid (area under ...
We compare Prostate Health Index, Prostate Health Index density, and PSA density in predicting clinically significant prostate cancer in MRI-guided prostate biopsy....
This is a multicenter evaluation of prospectively maintained prostate biopsy databases at 10 urology centers. Men with Prostate Health Index and MRI-guided targeted and systematic prostate biopsy perf...
A total of 1,215 men were analyzed. Prostate cancer and clinically significant prostate cancer were diagnosed in 51% (617/1,215) and 35% (422/1,215) of men, respectively. Clinically significant prosta...
Prostate Health Index density outperformed Prostate Health Index or PSA density in clinically significant prostate cancer detection in men with multiparametric MRI performed, and further reduced unnec...